A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication
NCT ID: NCT00879736
Last Updated: 2011-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
322 participants
INTERVENTIONAL
2009-03-31
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The TEACH (Texting After ACS Discharge) Pilot Randomized Trial
NCT05628337
My Health - My Medication. Patient Involvement in Administration of Medication
NCT02894814
The Impact Of Physician Communication On Family Inpatient Experience
NCT01298791
The Influence of Doctor-patient Communication on Treatment Expectation, Placebo and Nocebo Response
NCT03949816
Improving Medication Adherence: A Study With Talking Pill Bottles
NCT02827773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
THT PACE eLearning module
The PACE (prepare, ask, check, express) training methodology will be available to patients before their 2nd doctor visit
THT PACE Training
Patient training
THT PACE eLearning module & nurse-led workshop training
THT PACE eLearning and then nurse-led workshop for training on PACE methodology
THT PACE Training
Patient training
Usual care
Patients just go to their doctor as they normally would but get some disease specific information in the form of brochures as do intervention arms
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
THT PACE Training
Patient training
THT PACE Training
Patient training
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical documentation of diagnosis not to target of at least one of the following: Type II Diabetes Mellitus, Hypertension or Hypercholesterolemia
* Receive a prescribed medication for the chronic disease for which they were included in the study
Exclusion Criteria
* Inability to carry out the encounter with their physician in English without need of assistance
* Uncomfortable using a computer for routine activities such as regular access to the web and e-mail.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Marie-Therese Lussier
UNKNOWN
Dr. Claude Richard
UNKNOWN
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Astrazeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Marie-Thérèse Lussier, MD, BSc., MSc., FCMFC
Role: PRINCIPAL_INVESTIGATOR
Université de Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Burlington, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Kitchener-Waterloo, Ontario, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
Oakville, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THT in practice
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.